Abstract
Background
Portal vein thrombus (PVT) in cirrhotic patients is associated with worsening portal hypertension, leads to increased complexity of necessary interventions such as transjugular liver portosystemic shunt or liver transplantation, and is associated with worse outcomes after liver transplantation. Additionally, there are no established consensus guidelines for management of bland PVT in cirrhotic patients, which currently exists on a spectrum and is patient and provider dependent.
Purpose
The aim of this study was to determine whether there are associations between key clinical and imaging variables and bland PVT burden over time.
Material and Methods
This exploratory, retrospective, single-center study included patients who underwent two or more multiphase CT or MRI examinations between 1/1/2013 and 12/31/2019 and had a diagnosis of PVT. Three readers independently evaluated all index and follow-up examinations for PVT burden using a proposed 8-point scale and the established Yerdel score. Key clinical factors were collected from the electronic medical record. The PVT burden over time and the association of this burden with key clinical and imaging variables were assessed using logistic regression models.
Results
138 patients with cirrhosis and bland PVT were included in the analyses. Median age was 60 years (interquartile range 55–67; 90 men) and median follow-up time was 19.6 months. At baseline, the mean score was 2.31 (± 1.44) and at the final follow-up examination, the mean score was 2.52 (± 1.99). Baseline occlusion level was the only statistically significant association with worsening PVT burden in all four vascular territories (p-value < 0.0001). Anticoagulation status did not have a statistically significant association with change in thrombus burden in any vascular territory or cumulative thrombus burden across all territories (p-value 0.11–0.43).
Conclusion
In conclusion, our study shows that in cirrhotic patients with bland PVT, the thrombus burden did not change significantly over time and baseline thrombus burden is the only clinical factor significantly associated with increasing burden over time.
Graphical abstract
Similar content being viewed by others
Abbreviations
- PVT:
-
Portal vein thrombus
- TIPS:
-
Transjugular intrahepatic portosystemic shunt
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
- OR:
-
Odds ratio
- SD:
-
Standard deviation
References
Chen H, Turon F, Hernández-Gea V, et al (2016) Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transplantation 22:352–365. doi: https://doi.org/10.1002/lt.24387
Harding DJ, Perera MT, Chen F, et al (2015) Portal vein thrombosis in cirrhosis: Controversies and latest developments. World Journal of Gastroenterology 21:6769–6784. doi: https://doi.org/10.3748/wjg.v21.i22.6769
Lakhoo J, Gaba RC (2016) Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis. Diagnostic and Interventional Imaging 97:1085–1093. doi: https://doi.org/10.1016/j.diii.2016.07.005
Ghabril M, Agarwal S, Lacerda M, et al (2016) Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation. Transplantation 100:126–133. doi: https://doi.org/10.1097/tp.0000000000000785
Francoz C (2005) Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation. Gut 54:691–697. doi: https://doi.org/10.1136/gut.2004.042796
Amitrano L, Guardascione MA, Menchise A, et al (2010) Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. Journal of Clinical Gastroenterology 44:448–451. doi: https://doi.org/10.1097/mcg.0b013e3181b3ab44
Loffredo L, Pastori D, Farcomeni A, Violi F (2017) Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: A systematic review and meta-analysis. Gastroenterology. doi: https://doi.org/10.1053/j.gastro.2017.04.042
Hall, T.C, Garcea, G, Metcalfe, M, Bilk, D, Rajesh, A, Dennison, A (2013) Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: A retrospective observational study. Hepato-Gastroenterology 60:121.
Villa E, Cammà C, Marietta M, et al (2012) Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. doi: https://doi.org/10.1053/j.gastro.2012.07.018
Northup PG, Garcia‐Pagan JC, Garcia‐Tsao G, et al (2021) Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the study of liver diseases. Hepatology 73:366–413. doi: https://doi.org/10.1002/hep.31646
Yerdel MA, Gunson B, Mirza D, et al (2000) Portal vein thrombosis in adults undergoing liver transplantation. Transplantation 69:1873–1881. doi: https://doi.org/10.1097/00007890-200005150-00023
Jundt MC, Owen RL, Thompson SM, et al (2021) Meld-na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization. Abdominal Radiology 47:416–422. doi: https://doi.org/10.1007/s00261-021-03306-2
Benchoufi M, Matzner-Lober E, Molinari N, et al (2020) Interobserver agreement issues in Radiology. Diagnostic and Interventional Imaging 101:639–641. doi: https://doi.org/10.1016/j.diii.2020.09.001
Maruyama H, Okugawa H, Takahashi M, Yokosuka O (2013) De novo portal vein thrombosis in virus-related cirrhosis: Predictive factors and long-term outcomes. American Journal of Gastroenterology 108:568–574. doi: https://doi.org/10.1038/ajg.2012.452
Luca A, Caruso S, Milazzo M, et al (2012) Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 265:124–132. doi: https://doi.org/10.1148/radiol.12112236
TRIPODI A, ANSTEE QM, SOGAARD KK, et al (2011) Hypercoagulability in cirrhosis: Causes and consequences1. Journal of Thrombosis and Haemostasis 9:1713–1723. doi: https://doi.org/10.1111/j.1538-7836.2011.04429.x
Sharma AM, Zhu D, Henry Z (2015) Portal vein thrombosis: When to treat and how? Vascular Medicine 21:61–69. doi: https://doi.org/10.1177/1358863x15611224
Martinez M, Tandra A, Vuppalanchi R (2014) Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology 60:425–426. doi: https://doi.org/10.1002/hep.26998
Intagliata NM, Ferreira CN, Caldwell SH (2016) Anticoagulation for portal vein thrombosis in cirrhosis. Clinical Liver Disease 7:126–131. doi: https://doi.org/10.1002/cld.552
Wu M, Schuster M, Tadros M (2019) Update on management of portal vein thrombosis and the role of novel anticoagulants. Journal of Clinical and Translational Hepatology 7:1–11. doi: https://doi.org/10.14218/jcth.2018.00057
Basit S, Stone C, Gish R (2015) Portal vein thrombosis. Clinics in Liver Disease 19(1):199-221.
Lee H, Lee H, Park S, et al. (2008) Portal vein thrombosis: CT features. Abdominal Imaging 33(1):72-79.
Rodrigues SG, Maurer MH, Baumgartner I, et al (2017) Imaging and minimally invasive endovascular therapy in the management of portal vein thrombosis. Abdominal Radiology 43:1931–1946. doi: https://doi.org/10.1007/s00261-017-1335-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors or this paper do not have any competing interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Konanur, M., Reynolds, C., Shropshire, E. et al. Clinical and imaging predictors of the natural course of bland portal vein thrombus in cirrhotic patients. Abdom Radiol 47, 3724–3732 (2022). https://doi.org/10.1007/s00261-022-03626-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03626-x